Author: Wierda WG, Byrd JC, Abramson JS, Bilgrami S, Bociek G, Brander D, Brown J, Chanan-Khan A, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Ma S, Malek S, Mato A, Mosse C, Neppalli VT, Shadman M, Siddiqi T, Stephens D, Wagner N, Dwyer M, Sundar H
Year: 2018
AGREE II score: Available
Developer organization: National Comprehensive Cancer Network
Type of cancer: Hematological
Patient population: Adult
Location: International
This is a clinical practice guideline for patients with chronic lymphocytic leukemia, or small lymphocytic lymphoma. The guideline examines the diagnosis, staging, treatment, and follow-up of these patients. Prognosis and treatment algorithms are presented based on patient characteristics such as age, and genetic profile.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 50%
Applicability: 54.2%
Stakeholder involvement: 38.9%
Editorial independence: 83.3%
Rigour: 69.8%
Clarity presentation: 66.7%
